Netherlands: EQT Life Sciences takes €25m of Onward’s €40m private placement
Euronext-listed Onward Medical, a medical technology company creating innovative therapies to restore movement, function, and independence in people with spinal cord injuries, has €40.6m by way...
UK: Charterhouse reaches agreement on recommended acquisition of Animalcare
Charterhouse Capital Partners has reached an agreement to acquire all shares of York-based AIM-listed international veterinary sales and marketing organisation, Animalcare, for approximately £235.2m on...
UK: Optima acquires PAM from LDC for £100m
Optima Health, one of the UK and Republic of Ireland’s leading occupational health and wellness service providers, has acquired PAM Healthcare, a leading preventative...
Malaysia: Sunway Healthcare shares up over 30% since IPO
Sunway Healthcare Group (SHG), an integrated private healthcare group with a network of hospitals and health services operating in Malaysia and Singapore, raised RM2.86bn...
UK: Bridgepoint and Triton back away from Spire Healthcare bid
Bridgepoint and Triton have dropped out of bidding for Spire Healthcare, according to regulatory releases from Spire made on 20 March. Earlier in the...
Switzerland: Alcon and Lensar agree to terminate merger agreement
Switzerland-based Alcon, the largest eye care device company in the world, has announced that the proposed merger with Lensar is being terminated.
In March 2025,...
UK: Savills agrees acquisition of Eastdil Secured for enterprise value of US$1.11bn
London-listed Savills, one of the world's leading real estate advisory firms, has agreed to acquire US-based global real estate investment bank Eastdil Secured Holdings, for...
Switzerland: Galderma buys back CHF232m as EQT, ADIA and Auba fully divest remaining stake
SIX-listed Galderma, the pure-play dermatology category leader, has agreed to repurchase 1.6 million shares at a price of CHF143.75 per share for a total consideration of CHF232m...
Switzerland: Lonza completing transformation to pure-play CDMO with divestment of Capsules & Health Ingredients
Switzerland-listed Lonza has agreed to sell its Capsules & Health Ingredients (CHI) business to UK-based Lone Star Funds for an enterprise value of CHF2.3bn...
Belgium: Aedifica to proceed with Cofinimmo merger following strong results to Exchange Offer
Belgium-based healthcare real estate REIT, Aedifica has reported a strong result after the initial acceptance period for Aedifica’s Exchange Offer on Cofinimmo.
During the initial...
Advertisement
